Gerresheimer expands capacities for Medical Systems in US

Germany-headquartered Gerresheimer is significantly expanding its production capacities for medical systems such as inhalers and autoinjectors in the United States.

In two expansion stages, Gerresheimer is expanding the production area at its Peachtree City site in the state of Georgia, USA, by around 18,000 m² (194,000 sqft). The company is investing a total of around 166 million euros ($180 million) in the construction and equipping of the two new buildings.

With the capacity expansions, Gerresheimer is creating more than 400 new jobs for skilled workers in Peachtree City. At the Peachtree site, Gerresheimer produces medical devices such as inhalers, components for infusion sets, microinjectors, test cards for microbiological tests, and autoinjectors, which can be used in diabetes and obesity therapy, among other things. With the expansion in Peachtree, Gerresheimer is also underscoring its leading market position as a system and solution provider for drug delivery systems in the North American market.

"North America is an important growth market for us. The expansion of the site in Peachtree City is of great importance for our medical device business in the USA," says Dietmar Siemssen, CEO of Gerresheimer AG.